Abstract
Neoantigens derived from somatic DNA alterations are ideal cancer-specific targets. In recent years, the combination therapy of PD-1/PD-L1 blockers and neoantigen vaccines has shown clinical efficacy in original PD-1/PD-L1 blocker non-responders. However, not all somatic DNA mutations result in immunogenicity among cancer cells and efficient tools to predict the immunogenicity of neoepitopes are still urgently needed. Here, we present the Seq2Neo pipeline, which provides a one-stop solution for neoepitope feature prediction using raw sequencing data. Neoantigens derived from different types of genome DNA alterations, including point mutations, insertion deletions and gene fusions, are all supported. Importantly, a convolutional neural network (CNN)-based model was trained to predict the immunogenicity of neoepitopes and this model showed an improved performance compared to the currently available tools in immunogenicity prediction using independent datasets. We anticipate that the Seq2Neo pipeline could become a useful tool in the prediction of neoantigen immunogenicity and cancer immunotherapy. Seq2Neo is open-source software under an academic free license (AFL) v3.0 and is freely available at Github.
Funder
National Natural Science Foundation of China
Shanghai Science and Technology Commission
ShanghaiTech University
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference43 articles.
1. Immunotherapy: Past, Present and Future;Waldmann;Nat. Med.,2003
2. Advances in Immunotherapy for Hepatocellular Carcinoma;Sangro;Nat. Rev. Gastroenterol. Hepatol.,2021
3. Ren, Y., Song, J., Li, X., and Luo, N. Rationale and Clinical Research Progress on PD-1/PD-L1-Based Immunotherapy for Metastatic Triple-Negative Breast Cancer. Int. J. Mol. Sci., 2022. 23.
4. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer;Topalian;N. Engl. J. Med.,2012
5. Antigen Presentation and Tumor Immunogenicity in Cancer Immunotherapy Response Prediction;Wang;Elife,2019
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献